Skip to content

Added to your cart:

Cart subtotal

Xembify Immune Globulin Subcutaneous, Human – klhw 20% Injection 5 mL **Requires Refrigeration

SKU 13533-0810-05
Sale 13%
Original price $ 429.95
Current price $ 375.00
In stock
Non-Returnable
*Mountainside Medical does not fill personal prescriptions Medical Professional License Required to Unlock Account

How to Order:

Send an email request to: sales@mountainside-medical.com

You will receive instructions on how to create an account along with Rx Ordering Details.

(Note: Acceptable licenses must have Prescriptive Authority in the license issuing state.)
Fast Delivery
Fast Delivery
24/7 Support
24/7 Support
No Returns
No Returns
Hospital Grade
Hospital Grade
Free Shipping on orders above $100
Payment Secure transaction
Packaging Ships in product packaging
Service-Disabled Veteran-Owned Small Business
Service-Disabled Veteran-Owned Small Business
Located in Adirondack Mountains in NY
Located in Adirondack Mountains in NY
Family Owned Business 2002
Family Owned Business 2002
Sale 13%
Original price $ 429.95
Current price $ 375.00
Free Shipping on orders above $100
Payment Secure transaction
Packaging Ships in product packaging
Xembify Immune Globulin Subcutaneous, Human – klhw 20% Injection 5 mL **Requires Refrigeration
Xembify Immune Globulin Subcutaneous, Human – klhw 20% Injection 5 mL **Requires Refrigeration
$ 429.95 $ 375.00
🔒 Medical License Required
Description

Xembify Immune Globulin Subcutaneous, Human – klhw 20% Injection 5 mL is a prescription medication used for the treatment of primary immunodeficiency (PI), a group of disorders in which the immune system is not functioning properly. It provides the body with antibodies that help to fight against infections. This medication is made from human plasma and is given as an injection under the skin (subcutaneously). It is also known as a subcutaneous immunoglobulin (SCIG) and is manufactured by Baxalta US Inc. Xembify is specifically formulated with the immune globulin klhw, which stands for kappa-free antibody in polysorbate. It is available in a 5 mL vial and contains 20% immune globulin.

Xembify Immune Globulin Subcutaneous, Human – klhw 20% (also known as Hizentra) is a medication used for replacement therapy in patients with primary immunodeficiency (PID). It is a solution of immunoglobulin G (IgG) antibodies that is injected under the skin (subcutaneously).

IgG antibodies are a type of protein that is naturally produced by the immune system to help fight off infections. In patients with PID, their immune system does not produce enough IgG antibodies, putting them at a higher risk for infections.

Xembify works by replacing the deficient IgG antibodies in patients with PID. This helps to boost their immune system and protect them against infections. The IgG antibodies in Xembify are extracted from healthy human blood donors and purified to remove any potential impurities.

Once injected under the skin, Xembify is absorbed into the bloodstream and circulates throughout the body, providing protection against a wide range of bacteria, viruses, and other pathogens. It also helps to reduce the frequency and severity of infections in patients with PID.

Overall, Xembify works to help improve and maintain the immune function of patients with PID. It is an important form of therapy that can greatly benefit these individuals and help them lead healthier lives.

Description

Xembify Immune Globulin Subcutaneous, Human – klhw 20% Injection 5 mL is a prescription medication used for the treatment of primary immunodeficiency (PI), a group of disorders in which the immune system is not functioning properly. It provides the body with antibodies that help to fight against infections. This medication is made from human plasma and is given as an injection under the skin (subcutaneously). It is also known as a subcutaneous immunoglobulin (SCIG) and is manufactured by Baxalta US Inc. Xembify is specifically formulated with the immune globulin klhw, which stands for kappa-free antibody in polysorbate. It is available in a 5 mL vial and contains 20% immune globulin.

Xembify Immune Globulin Subcutaneous, Human – klhw 20% (also known as Hizentra) is a medication used for replacement therapy in patients with primary immunodeficiency (PID). It is a solution of immunoglobulin G (IgG) antibodies that is injected under the skin (subcutaneously).

IgG antibodies are a type of protein that is naturally produced by the immune system to help fight off infections. In patients with PID, their immune system does not produce enough IgG antibodies, putting them at a higher risk for infections.

Xembify works by replacing the deficient IgG antibodies in patients with PID. This helps to boost their immune system and protect them against infections. The IgG antibodies in Xembify are extracted from healthy human blood donors and purified to remove any potential impurities.

Once injected under the skin, Xembify is absorbed into the bloodstream and circulates throughout the body, providing protection against a wide range of bacteria, viruses, and other pathogens. It also helps to reduce the frequency and severity of infections in patients with PID.

Overall, Xembify works to help improve and maintain the immune function of patients with PID. It is an important form of therapy that can greatly benefit these individuals and help them lead healthier lives.

Get Notified When Back in Stock